市场调查报告书
商品编码
1597058
北美素食胶囊市场预测至 2031 年 - 区域分析 - 按产品、应用、功能和最终用户North America Vegetarian Capsules Market Forecast to 2031 - Regional Analysis - by Product, Application, Functionality, and End User |
2023年北美素食胶囊市值为5.0363亿美元,预计到2031年将达到9.7633亿美元;预计2023年至2031年复合年增长率为8.6%。
与明胶胶囊相比,人们对纯素胶囊的偏好不断上升,推动了北美素食胶囊市场
大多数製药公司都采购素食胶囊而不是动物性胶囊,因为它们的水分含量低,并且对吸湿性化合物具有更好的稳定性。多年来,医学、宗教、文化和伦理方面一直对在药物的胶囊包衣或配方中添加动物物质存在担忧。此外,由于相关的医疗风险,一些消费者对使用动物性药物表示担忧。 2023 年7 月,美国疾病管制与预防中心(CDC) 发布了一份针对Alpha-gal 症候群(AGS) 患者的报告,限制动物性药物和补充剂的消费,因为这些药物中75% 含有动物源性成分。此外,AGS 患者在服用含有哺乳动物成分的药物或补充剂后表现出严重的过敏反应。这些情况引起了製造商生产非动物药物和补充剂的兴趣。
明胶胶囊与素食胶囊的比较分析
因素
明胶胶囊
素食胶囊
来源
牛、皮、牛和猪
植物
目标受众
素食和非素食人口
素食主义者或素食人口
过敏
对牛和猪成分过敏
无过敏
交联成分
与其他药物-药物衍生物的交联
无交叉连结
外部成分
防腐剂
不含防腐剂
目前,市面上大量的药物胶囊由明胶组成。然而,明胶的交联与药物不相容性以及对动物源明胶使用的严格规定鼓励製药商用植物成分替代明胶成分。製药商发现,羟丙基甲基纤维素 (HPMC) 衍生的素食胶囊由于其植物来源,是明胶的良好替代品。 Vegicaps 软胶囊是不含动物成分的胶囊的最佳例子。外壳由海藻萃取物和无麸质淀粉组成,不含改性糖和人工色素。 Vegicaps软胶囊的优点是不含动物衍生物、易于吞嚥、柔软、天然、更健康的产品。对于明胶胶囊,在喷涂水性肠溶聚合物分散体时,壳可能会变软并变粘,或者可能由于干燥过程中水分蒸发而变脆,最终失去机械稳定性。然而,在 HPMC 衍生的素食胶囊中,它对水性包衣不太敏感,并且胶囊壳坚硬,可以避免成分洩漏。
因此,对素食药物的日益青睐有利于製造商加速素食胶囊的生产,从而推动北美素食胶囊市场的成长。
北美素食胶囊市场概况
根据美国整骨协会 (AOA) 2024 年报告中发布的资料,在美国,超过五分之四的美国成年人 (86%) 食用维生素或膳食补充剂。报告显示,美国成年人出于个人需求或医生、朋友或家人的建议而消费维生素或营养保健品。此外,随着维生素缺乏症盛行率的上升,美国人口对胶囊等营养补充品的消耗量也很高。 2023 年 CRN 膳食补充剂消费者调查显示,近 74% 的美国成年人食用膳食补充剂,其中 55% 是一般消费者。一些美国人正在转向纯素饮食。注重健康的纯素食消费者在购买营养保健品和其他膳食补充品产品时会寻找「纯素食商标」。
在美国,营养保健品产业提供创新的纯素产品,以满足不断增长的消费者需求以及多样化的消费者摄取转向无动物成分膳食补充剂的趋势。 2023年4月,IFF宣布推出「VERDIGEL SC」。 「VERDIGEL SC」的推出使纯素软胶囊製造商能够提供在多个市场需求量很大的不含角叉菜胶的产品。软胶囊在营养和补充剂领域越来越受欢迎,IFF 开发的这款新产品为製造商提供了一个合适的选择,可以在不破坏现有生产流程、不影响性能和品质的情况下转向基于植物的、不含角叉菜胶的替代品。
北美素食胶囊市场收入及 2031 年预测(百万美元)
北美素食胶囊市场细分
北美素食胶囊市场按产品、应用、功能、最终用户和国家进行分类。
根据产品,北美素食胶囊市场分为羟丙基甲基纤维素(HPMC)、普鲁兰多醣等。 2023 年,羟丙基甲基纤维素 (HPMC) 领域占据最大的市场份额。
从应用来看,北美素食胶囊市场分为抗生素和抗菌药物、维生素和膳食补充剂、抗发炎药物、心血管治疗药物、抗酸和抗胀气製剂等。 2023年,抗生素和抗菌药物领域占最大的市场。
依功能划分,北美素食胶囊市场分为速释胶囊、缓释胶囊和缓释胶囊。 2023 年,速释胶囊细分市场占据更大的市场份额。
按最终用户划分,北美素食胶囊市场分为製药公司、营养保健品公司、合约製造组织 (CMOS) 和药妆公司。 2023 年,製药公司细分市场占据最大的市场。
按国家/地区划分,北美素食胶囊市场分为美国、加拿大和墨西哥。 2023 年,美国主导北美素食胶囊市占率。
二次元;加拿大帽; Capsugel, Inc(Lonza Group AG 的子公司);印度健康帽; Lefancaps;天然胶囊有限公司;品质;山西广生药用胶囊有限公司(GS胶囊);苏尼尔医疗保健有限公司;亚辛;和浙江迴力胶囊有限公司是北美素食胶囊市场的领导公司。
The North America vegetarian capsules market was valued at US$ 503.63 million in 2023 and is expected to reach US$ 976.33 million by 2031; it is estimated to register a CAGR of 8.6% from 2023 to 2031.
Rising Preference for Vegan Capsules Over Gelatin-Based Capsules Fuels North America Vegetarian Capsules Market
The majority of pharmaceutical companies are procuring vegetarian capsules over animal-derived capsules as they have low moisture content and better stability for hygroscopic compounds. For many years, there have been medical, religious, cultural, and ethical concerns about adding animal substances to capsule coatings or formulations in pharmaceutical medicines. Also, some consumers expressed concerns over the use of animal-derived pharmaceutical medicines due to the associated healthcare risks. In July 2023, the Center for Disease Control and Prevention (CDC) published a report for Alpha-gal syndrome (AGS) patients to limit the consumption of animal-derived medicines and supplements, as 75% of these medications contain animal-sourced ingredients. Also, AGS patients revealed serious allergic reactions after consuming medications or supplements that include mammalian-derived ingredients. Such instances have raised interest among the manufacturers to produce animal-free medications and supplements.
Comparative Analysis Between Gelatin Capsules and Vegetarian Capsules
Factors
Gelatin Capsules
Vegetarian Capsules
Source
Bovine, Skin, Cow, and Pigs
Plants
Target Audience
Vegan and Nonvegetarian Population
Vegan or Vegetarian Population
Allergy
Allergy Due to Cow and Pig-Based Ingredient
No Allergies
Cross Linking Ingredients
Cross Linking with Other Drug-Drug Derivatives
No Cross Linking
External Ingredients
Preservatives
No Preservatives
Currently, the high volume of pharmaceutical capsules available in the market are composed of gelatin. However, the crosslinking of gelatin with drug incompatibilities and strict regulations on the use of animal-derived gelatin have encouraged pharmaceutical manufacturers to replace gelatin components with vegetable-based ingredients. Pharmaceutical manufacturers identified that Hydroxypropyl Methylcellulose (HPMC)-derived vegetarian capsules are a good alternative to gelatin due to its vegetable derived source. Vegicaps soft capsules are the best example of animal-free capsules. The shell is composed of seaweed extract and gluten-free starch containing no modified sugars and artificial colors. Advantages of Vegicaps soft capsules are that they are free from animal derivatives, easy to swallow, soft, natural, and healthier products. In the case of gelatin-based capsules, the shell may get soft and become sticky upon spraying aqueous enteric polymer dispersions or may become brittle due to water evaporation during drying, ultimately losing mechanical stability. However, in HPMC-derived vegetarian capsules, it is less sensitive to aqueous coating, and the capsule shell is hard that avoids leakage of the ingredients.
Therefore, rising preference toward vegetarian medicines proves advantageous for the manufacturers to accelerate the production of vegetarian capsules, which drives the North America vegetarian capsules market growth.
North America Vegetarian Capsules Market Overview
According to data published in the American Osteopathic Association (AOA) report in 2024, in the US more than 4 in 5 American adults (86%) consume vitamins or dietary supplements. The report reveals that American adults consume vitamins or nutraceuticals due to personal needs or recommendations by physicians, friends, or family members. Also, with the rising prevalence of vitamin deficiency, the consumption of nutraceutical supplements such as capsules is high among the US population. The 2023 CRN Consumer Survey on Dietary Supplements shows that almost 74% of adults in the US consume dietary supplements, among which 55% are regular consumers. Some US population is shifting toward vegan diet. Health-conscious vegan consumers look for the "Vegan Trademark" while purchasing nutraceuticals and other dietary supplement products.
In the US, the nutraceutical industry provides innovative vegan products to meet rising consumer demand and diverse consumer intake shift toward animal-free dietary supplements. In April 2023, IFF announced the launch of "VERDIGEL SC". The introduction of "VERDIGEL SC" enables manufacturers of vegan soft gels to offer carrageenan-free products that are in high demand in several markets. Softgels are gaining high popularity in the nutritional and supplement sectors, and this new product developed by the IFF offers manufacturers a suitable option to switch to plant-based, carrageenan-free alternatives without disrupting existing production processes and compromising performance and quality.
North America Vegetarian Capsules Market Revenue and Forecast to 2031 (US$ Million)
North America Vegetarian Capsules Market Segmentation
The North America vegetarian capsules market is categorized into product, application, functionality, end user, and country.
Based on product, the North America vegetarian capsules market is segmented hydroxypropyl methylcellulose (HPMC), pullulan, and others. The hydroxypropyl methylcellulose (HPMC) segment held the largest market share in 2023.
In terms of application, the North America vegetarian capsules market is categorized into antibiotic and antibacterial drug, vitamin and dietary supplement, anti-inflammatory drugs, cardiovascular therapy drugs, antacid and antiflatulent preparation, and others. The antibiotic and antibacterial drug segment held the largest market share in 2023.
By functionality, the North America vegetarian capsules market is segmented into immediate release capsules, sustained release capsules, and delayed release capsules. The immediate release capsules segment held the larger market share in 2023.
By end user, the North America vegetarian capsules market is segmented into pharmaceutical companies, nutraceutical companies, contract manufacturing organizations (CMOS), and cosmeceutical companies. The pharmaceutical companies segment held the largest market share in 2023.
By country, the North America vegetarian capsules market is segmented into the US, Canada, and Mexico. The US dominated the North America vegetarian capsules market share in 2023.
ACG; CapsCanada; Capsugel, Inc (A subsidiary of Lonza Group AG); HealthCaps India; Lefancaps; NATURAL CAPSULES LIMITED; QUALICAPS; Shanxi Guangsheng Medicinal Capsules Co (GS Capsules); Sunil Healthcare Limited; Yasin; and Zhejiang Huili Capsules Co., Ltd. are some of the leading companies operating in the North America vegetarian capsules market.